Solutex
Solutex is a Spain-based B2B manufacturer of highly concentrated omega-3 EPA and DHA ingredients and patented SPM lipid fractions, supplying dietary supplement, medical nutrition, pharmaceutical, and cosmetics formulators worldwide via proprietary supercritical CO2 extraction technology and exclusive distribution partnerships.
- Company typePrivate
- Founded2004
- HeadquartersAlcobendas, Spain
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Solutex does
Solutex GC S.L. is a Spain-based, privately held B2B ingredient manufacturer founded in 2004 and headquartered in Alcobendas, Madrid, with a dedicated manufacturing and laboratory campus in Mallén, Zaragoza. The company produces highly concentrated omega-3 EPA and DHA ingredients and Specialized Pro-Resolving Mediators (SPMs), selling to dietary supplement, medical nutrition, pharmaceutical, and cosmetics manufacturers across more than four continents via direct B2B sales and regional distribution.
Its product portfolio is anchored on four ingredient brands — Omegatex Marine Sourced, Omegatex Plant Based (algal, vegan), MaGOmega (microalgae monoglyceride form), and Lipinova (SPM concentrate) — all enabled by a proprietary technology stack centered on Flutex supercritical CO2 fluid extraction and chromatography (enabling up to 97% EPA potency and GRAS status), Cleantex purification and deodorization (patented for heavy metal, PCB, and dioxin removal), and Emugel nano-emulsion for water-soluble delivery. Manufacturing follows a zero-waste, circular-economy model certified under multiple ISO standards, IFOS, Friend of the Sea, GOED, IFFO, Kosher, Halal, and V-Label Vegan.
Solutex monetizes primarily through one-time bulk ingredient sales to brand owners and OEMs, augmented by pharmaceutical licensing (inbound Maresins 1 license from Harvard, developed through subsidiary Maresins BioPharma), specialized Resolution Physiology Laboratory services for SPM bioactivity validation, and an exclusive EU27 distribution agreement with BTC Europe (BASF group) signed April 2, 2025. Pricing is quote-based B2B; the company holds a significant minority stake investment from Nexxus Iberia private equity (January 2022) and operates wholly-owned subsidiaries Azur Global Nutrition (SPM nutrition) and Maresins BioPharma (pharmaceuticals).
Solutex firmographics
Firmographics- Name
- Solutex
- Legal name
- SOLUTEX GC S.L.
- Website
- https://solutexcorp.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Solutex is a Spain-based B2B manufacturer of highly concentrated omega-3 EPA and DHA ingredients and patented SPM lipid fractions, supplying dietary supplement, medical nutrition, pharmaceutical, and cosmetics formulators worldwide via proprietary supercritical CO2 extraction technology and exclusive distribution partnerships.
- Ownership category
- akta.pro rank
Solutex industry classification
Industry- Product category
- Omega-3 Nutritional Ingredients
- NAICS
- Fats and Oils Refining and Blending (311225)
- SIC
- Fats & Oils (2070), Medicinal Chemicals & Botanical Products (2833), Miscellaneous Chemical Products (2890)
- akta.pro primary industry
- Omega-3 & Specialty Lipids (Fish/Algal Oils, EPA/DHA, MCTs, CLA, Phospholipids) (AFAJAKAC)
- akta.pro secondary industries
- Omega-3 & Marine/Algal Lipids (EPA/DHA Oils, Concentrates) (AFAJALAK), Condition-Specific Bioactives (Glucosamine/Chondroitin, Plant Sterols, Melatonin, Lutein/Zeaxanthin) (AFAJAKAK), Ingredient Blends & Systems / Custom Formulation (Seasoning Systems, Functional Blends) (CRADAOAO)
Keywords
Where Solutex is headquartered
LocationHeadquarters
- HQ city
- Alcobendas
- HQ country
- Spain
- HQ region
- Europe
Offices5 records
Markets served
Solutex business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Omega-3 Bulk Ingredients: Sale of bulk omega-3 ingredients including Omegatex Marine Sourced, Omegatex Plant Based, MaGOmega, and Lipinova to dietary supplements, medical nutrition, pharmaceutical and cosmetics manufacturers. Products sold in various forms (EE, TG, DG, MAG) with customized ratios and potencies. Revenue generated through direct B2B sales and distribution partnerships.
- Pharmaceutical Licensing: Licensing of SPM patents including Maresins from Harvard University for pharmaceutical ingredient development. Development of pharmaceutical applications from SPM Maresins 1 as potent immunoresolvant through subsidiary Maresins BioPharma.
- Resolution Physiology Laboratory Services: Specialized laboratory services to observe SPM activity levels and inflammatory parameters in biological samples. Supports customer product development and validates SPM ingredient efficacy.
Go-to-market motion3 records
Distribution channels3 records
Marketing channels6 records
Solutex product offering
Product offeringCore offering
Solutex manufactures and sells highly concentrated omega-3 EPA and DHA fatty acid ingredients sourced from fish oil and microalgae, as well as patented Specialized Pro-Resolving Mediators (SPM) ingredients, serving dietary supplements, medical nutrition, pharmaceutical, and cosmetics manufacturers. Products are offered under the Omegatex, MaGOmega, and Lipinova brands with customizable potencies (up to 97% EPA), ratios, and delivery formats (EE, TG, DG, MAG).
Product overview
Solutex is a leading global manufacturer of omega-3 ingredients and Specialized Pro-Resolving Mediators (SPMs) for the dietary supplements, medical nutrition, pharmaceutical, and cosmetics industries. The company operates as a unified portfolio centered on four core ingredient brands: Omegatex® Marine Sourced (sustainably sourced marine omega-3 concentrates), Omegatex® Plant Based (vegan omega-3 from microalgae), MaGOmega® (enhanced-bioavailability monoglyceride omega-3), and Lipinova® (next-generation SPM ingredients for inflammation resolution). These products are enabled by Solutex's proprietary technology platforms—Flutex® (supercritical CO2 extraction and chromatography), Cleantex® (purification and deodorization), and Emugel™ (nano-emulsion for water solubility)—all backed by the SLTEX Warranty Seal® quality commitment. Ingredients are manufactured in Europe (Spain) for global brands.
Differentiator
Problem solved
Functional benefit
Brands
- Omegatex: Premium omega-3 ingredient brand including Marine Sourced (fish oil) and Plant Based (algae oil) product lines offering EPA and DHA concentrates
- MaGOmega
- Lipinova
- Flutex
- Cleantex
- Emugel
- SLTEX Warranty Seal
Products and services
- Omegatex® Marine Sourced Premium marine omega-3 concentrations sustainably sourced from fish oil, offering tailored EPA/DHA ratios up to 97% EPA, 90% DHA, and 35% DPA. Available in EE, TG, DG, and MAG forms with Cleantex® deodorization for reduced fishy aftertaste. Shelf life of 36 months. Targeted at dietary supplement, medical nutrition, pharmaceutical, and cosmetics manufacturers.
- Omegatex® Plant Based
Quantifiable outcome
- Omega-3 concentrates up to 97% EPA potency achievable through Flutex technology
- +3 more outcomes
Companies that use Solutex
Customer profileSegments4 records
Ideal customer profiles4 records
Solutex technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Solutex partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core, minor and major.
- BTC EuropecoreMutual exclusive distribution agreement for Omegatex brand omega-3 products across EU27 countries. BTC Europe, part of BASF, distributes fish oil and algae oil based Omega-3 products including marine-sourced (with Halal certification) and plant-based (with Kosher & Halal certifications) ingredients. Partnership enables customers to enhance product offerings with sustainably sourced ingredients and expand market reach in Europe.
- La Catedra Solutex / University of ZaragozaminorLa Catedra Solutex de Quimica Sostenible at University of Zaragoza. Grants two scholarships for Master's degree and internship at Solutex. Organized jointly with Fundacion Ramon Areces for Inflammation Treatment symposium.
- ANIMO3 / Government of AragonminorANIMO3 project (Research and valorization of non-concentrable side fractions as specialized Omega-3 animal feed) subsidized by Government of Aragon within circular economy projects. Valorization of omega-3 side streams for animal nutrition.
- Government of Aragon / ARACOVminorARACOV project co-financed 50% by Department of Economy, Planning, and Employment of Government of Aragon (File IDMF/2021/0008). Research trial evaluating improvement in quality of life of Persistent Covid patients through nutritional intervention with SPMs (Lipinova) along with exercise and therapeutic education program.
- MACBETH Consortium (Horizon 2020)majorMACBETH (Membranes And Catalysts Beyond Economic and Technological Hurdles) project received funding from EU Horizon 2020 research program (grant agreement No 869896). Develops breakthrough technology combining catalytic synthesis with separation units in catalytic membrane reactor for omega-3 enrichment.
- Harvard University / Dr. Charles SerhancorePartnership with Dr. Charles Serhan at Harvard Medical School led to discovery of SPMs (Specialized Pro-Resolving Mediators) and development of Lipinova. Dr. Serhan serves as Chairman of Scientific Committee of Solutex. Collaboration on SPM research and inflammation resolution science.
Scale indicators5 records
Recent moves8 records
Expansion highlights6 records
Solutex competitors and assessment
Company assessmentDirect peers
- GC Rieber Oils: Norwegian fish-oil refiner and omega-3 ingredient supplier producing EPA/DHA concentrates for nutrition and pharma. Direct competitor in marine-sourced omega-3 with overlapping customer base in European supplement brands and similar mid-sized positioning to Solutex.
- Aker BioMarine: Norwegian krill oil and marine ingredient specialist with Superba krill oil and QRILL Aqua feed products. Competes with Solutex's marine-sourced Omegatex for premium-positioned omega-3 customers and shares the focus on differentiated, science-backed marine lipid ingredients.
- KD Pharma Group: Contract manufacturer of omega-3 EPA/DHA concentrates and custom lipid formulations for pharma and nutraceutical customers. Closest direct peer to Solutex in terms of high-potency omega-3 manufacturing for B2B customers, with overlapping technology platforms.
Broad incumbents
- dsm-firmenich: Global nutrition and health ingredient conglomerate with the life'sDHA algal omega-3 brand and broad fish-oil portfolio serving dietary supplements, infant nutrition, and pharma. Competes with Solutex across both marine and plant-based omega-3 categories with much larger scale and customer reach.
- Croda International: UK-listed specialty ingredient company with Incromega fish-oil omega-3 concentrates and plant-based equivalents serving nutrition, personal care, and pharma. Comparable product formats, EPA/DHA potency positioning, and application breadth with significantly larger scale.
- BASF: World's largest chemical company with a Human Nutrition division including omega-3 ingredients, and parent of BTC Europe — Solutex's new exclusive EU distributor. Overlaps with Solutex on omega-3 ingredients and is the most strategically important adjacent incumbent given the partnership.
- Cargill: Global agribusiness and ingredient giant with omega-3 ingredients and EPA/DHA-containing oils via its health and nutrition division. Competes with Solutex as a broad incumbent supplying food, supplement, and animal nutrition customers with marine and alternative omega-3 sources.
Emerging players
- Polaris (part of Aker BioMarine): French omega-3 specialty ingredient company acquired by Aker BioMarine, focused on high-concentration EPA/DHA ingredients and phospholipid formats. Comparable mid-sized European positioning to Solutex and a relevant competitor in premium-concentrate omega-3.
- AlgiSys: US-based microalgae omega-3 (EPA/DHA) producer using Schizochytrium fermentation. Closest emerging competitor to Solutex's Omegatex Plant-Based and MaGOmega lines, focused on the same plant-based, vegan-positioned omega-3 segment.
- Corbion: Dutch ingredient company with algal-based omega-3 (DHA from Crypthecodinium cohnii) sold under the life'sDHA brand historically, now divested but adjacent in fermentation-derived lipid ingredients. Comparable technology positioning and European mid-market scale.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Solutex social profiles
Digital presenceSolutex compliance and trust
Trust signalCompliance17 records
Solutex financial estimates
Financial estimateRevenue estimate
Valuation estimate
Solutex leadership team
Management profileNumber of profiles
Profiles3 records
Solutex subsidiaries and ownership
Company hierarchySubsidiaries2 records
Solutex funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Solutex M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Solutex
What does Solutex do?
Solutex manufactures and sells highly concentrated omega-3 EPA and DHA fatty acid ingredients sourced from fish oil and microalgae, as well as patented Specialized Pro-Resolving Mediators (SPM) ingredients, serving dietary supplements, medical nutrition, pharmaceutical, and cosmetics manufacturers. Products are offered under the Omegatex, MaGOmega, and Lipinova brands with customizable potencies (up to 97% EPA), ratios, and delivery formats (EE, TG, DG, MAG).
Is Solutex a public or private company?
Solutex is a private company. It is classified as family owned and is currently operating.
When was Solutex founded?
Solutex was founded in 2004. It employs 101 to 250 people.
Where is Solutex based?
Solutex is headquartered in Alcobendas, Spain, in the Europe region.
How does Solutex make money?
Three revenue lines are on record. Omega-3 Bulk Ingredients are the primary driver. The others are pharmaceutical Licensing and resolution Physiology Laboratory Services.
Who are Solutex's main competitors?
Direct peers on record are GC Rieber Oils, Aker BioMarine and KD Pharma Group. Broad incumbents are dsm-firmenich, Croda International, BASF and Cargill. Emerging players are Polaris (part of Aker BioMarine), AlgiSys and Corbion.
Does Solutex have an API?
No public API is recorded for Solutex.
What industry is Solutex in?
Solutex's product category is Omega-3 Nutritional Ingredients. Its primary akta.pro industry code is AFAJAKAC, Omega-3 & Specialty Lipids (Fish/Algal Oils, EPA/DHA, MCTs, CLA, Phospholipids), with a secondary code of AFAJALAK, Omega-3 & Marine/Algal Lipids (EPA/DHA Oils, Concentrates). Its NAICS code is 311225 and its SIC code is 2070.